Total Payments
$5,101
2024 Payments
$992.35
Companies
33
Transactions
295
Medicare Patients
7,100
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$5,101 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,101 | 295 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,030 | 59 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $588.16 | 31 | $0 (2024) |
| ABBVIE INC. | $452.84 | 48 | $0 (2023) |
| Abbott Laboratories | $411.96 | 11 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $365.67 | 19 | $0 (2021) |
| SCILEX PHARMACEUTICALS INC. | $276.67 | 18 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $203.26 | 11 | $0 (2021) |
| Amgen Inc. | $171.95 | 9 | $0 (2022) |
| GRT US Holding, Inc. | $163.42 | 13 | $0 (2022) |
| Egalet US Inc | $160.43 | 16 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $992.35 | 45 | Collegium Pharmaceutical, Inc. ($243.93) |
| 2023 | $865.83 | 49 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($254.43) |
| 2022 | $1,202 | 75 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($322.82) |
| 2021 | $992.64 | 58 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($291.64) |
| 2020 | $313.15 | 20 | Boston Scientific Corporation ($165.25) |
| 2019 | $277.02 | 14 | Boston Scientific Corporation ($186.06) |
| 2018 | $305.50 | 18 | BioDelivery Sciences International, Inc. ($190.67) |
| 2017 | $152.73 | 16 | Egalet US Inc ($148.44) |
All Payment Transactions
295 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $165.69 | General |
| Category: Neuromodulation | ||||||
| 12/26/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Neuromodulation | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: PAIN | ||||||
| 12/03/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $25.98 | General |
| 11/21/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $23.41 | General |
| 11/20/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/20/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/01/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Neuromodulation | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/23/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/08/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.05 | General |
| Category: Opioid Analgesic | ||||||
| 10/03/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Analgesic | ||||||
| 09/26/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/09/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/04/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.31 | General |
| Category: Opioid Analgesic | ||||||
| 08/28/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: PAIN | ||||||
| 07/24/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.71 | General |
| Category: Opioid Analgesic | ||||||
| 07/16/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.02 | General |
| Category: Opioid Analgesic | ||||||
| 07/16/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/10/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.15 | General |
| Category: Opioid Analgesic | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Gastroenterology | ||||||
| 05/20/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.90 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,182 | 7,024 | $1.3M | $480,478 |
| 2022 | 15 | 1,872 | 6,231 | $1.2M | $393,488 |
| 2021 | 12 | 1,550 | 5,007 | $1.2M | $473,342 |
| 2020 | 15 | 1,496 | 3,999 | $822,287 | $275,280 |
Total Patients
7,100
Total Services
22,261
Medicare Billing
$1.6M
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 663 | 3,595 | $524,183 | $193,478 | 36.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 317 | 1,719 | $319,768 | $123,900 | 38.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 359 | 405 | $164,450 | $47,809 | 29.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 212 | 357 | $74,913 | $28,709 | 38.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 189 | 204 | $68,755 | $25,168 | 36.6% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 51 | 68 | $33,592 | $16,213 | 48.3% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 46 | 62 | $24,676 | $12,076 | 48.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 71 | 132 | $16,500 | $7,856 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 113 | $30,103 | $6,053 | 20.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 31 | 43 | $10,245 | $3,117 | 30.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 13 | 60 | $8,470 | $3,016 | 35.6% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 11 | 39 | $4,422 | $2,617 | 59.2% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 12 | 44 | $8,680 | $2,330 | 26.8% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 20 | 22 | $6,031 | $2,293 | 38.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 24 | 58 | $7,088 | $2,031 | 28.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $4,987 | $1,607 | 32.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 19 | 21 | $3,124 | $687.28 | 22.0% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 21 | 21 | $2,566 | $437.86 | 17.1% |
| 64420 | Injection of anesthetic agent and/or steroid into rib nerve | Facility | 2023 | 11 | 11 | $2,264 | $400.74 | 17.7% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Facility | 2023 | 12 | 12 | $1,924 | $345.72 | 18.0% |
| 64421 | Injection of anesthetic agent and/or steroid into multiple rib nerves for regional nerve block | Facility | 2023 | 11 | 20 | $1,389 | $333.65 | 24.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 601 | 3,705 | $541,028 | $180,858 | 33.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 228 | 1,097 | $203,788 | $67,969 | 33.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 335 | 384 | $156,023 | $52,076 | 33.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 222 | 410 | $85,992 | $28,806 | 33.5% |
About Daniel Hatmaker, D.C., NP-C
Daniel Hatmaker, D.C., NP-C is a Chiropractor healthcare provider based in Galveston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1366615866.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Hatmaker, D.C., NP-C has received a total of $5,101 in payments from pharmaceutical and medical device companies, with $992.35 received in 2024. These payments were reported across 295 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,101).
As a Medicare-enrolled provider, Hatmaker has provided services to 7,100 Medicare beneficiaries, totaling 22,261 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Chiropractor
- Other Specialties Family
- Location Galveston, TX
- Active Since 04/07/2008
- Last Updated 11/15/2016
- Taxonomy Code 111N00000X
- Entity Type Individual
- NPI Number 1366615866
Products in Payments
- RELISTOR (Drug) $1,030
- PROCLAIM (Device) $388.59
- XTAMPZA (Drug) $342.15
- NURTEC ODT (Drug) $289.25
- UBRELVY (Drug) $247.35
- Belbuca (Drug) $246.01
- ZTLido (Drug) $205.87
- Aimovig (Biological) $171.95
- QULIPTA (Drug) $167.23
- SPECTRA WAVEWRITER (Device) $163.87
- Qutenza (Drug) $163.42
- GENERAL - PAIN MANAGEMENT (Device) $163.22
- PAINTEQ (Device) $140.86
- mild Device Kit (Device) $139.82
- BELBUCA (Drug) $137.59
- ARYMO ER (Drug) $137.09
- BOTOX (Biological) $119.58
- VYEPTI (Biological) $108.47
- Movantik (Drug) $77.61
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $70.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Chiropractor Doctors in Galveston
Mary Brechtel, D.c. Dacbn, D.C. DACBN
Chiropractor
Chiropractor
Rita Sealy, Dc, DC
Chiropractor
Chiropractor
Dr. Donna Sanders, D.c, D.C
Chiropractor
Chiropractor
Dr. Chad Duchon, D. C, D. C
Chiropractor
Chiropractor
Dr. Anello D'ambra, D.c, D.C
Chiropractor
Chiropractor
Dr. Sheri Coleman, Dc, DC
Chiropractor
Chiropractor